San Diego, California-based biotech company Debut has announced that it has signed an agreement with L'Oréal to develop more than a dozen bio-identical ingredients to replace conventional ingredients currently used in the group's products.
As part of this agreement, Debut will create new biobased ingredients using proprietary advanced biomanufacturing processes that combine fermentation and cell-free technology to replace conventional methods.
The Californian biotech emphasizes that green sciences such as its biotechnological processes are paving the way for a new generation of bioactive cosmetic ingredients and products that combine the best of nature with supply chain transparency, safety, purity, consistency, quality and scientific data.
"Creating bio-identical ingredients on a large scale preserves global biodiversity and ensures responsible ingredient supply chains while continuing to prioritize product quality and performance.said the founder and CEO of the young American company. Debut is committed to creating bio-based formulations for all its beauty products and has unrivalled biotechnology, formulation and scale-up capabilities to catalyze this transformative change in beauty."
Debut's biotechnological processes pave the way for a new generation of bioactive cosmetic ingredients and products that combine the best of nature with supply chain transparency, safety, purity, consistency, quality and scientific data.
"Thanks to this exciting partnership and the adoption of groundbreaking technology, we are well placed to foster the creation of more sustainable and efficient products that meet the demands of our consumers and fulfill our duty to protect the planet.said Guive Balooch, Global Managing Director of Augmented Beauty and Open Innovation at L'Oréal Groupe. This long-term agreement with Debut is another example of our commitment to the Open Innovation ecosystem and to building the future of beauty by collaborating with the best partners."
Joshua Britton continues: "Our mission is to lead the way in biotechnology. We create value throughout the supply chain, ensuring that Debut's bio-identical and novel ingredients and products meet the huge global market demand for next-generation sustainable beauty. The beauty industry will be transformed, for the greater good of people and the planet."
Debut is a portfolio company of Bold, L'Oréal's venture capital fund.
Photo: Joshua Britton, founder and CEO of Debut, Ph.D.
